Intrathecal humoral immune response in HAM/TSP in relation to HLA haplotype analysis

被引:10
作者
Kitze, B
Usuku, K
Yashiki, S
Ijichi, S
Fujiyoshi, T
Nakamura, M
Izumo, S
Osame, M
Sonoda, S
机构
[1] KYUSHU UNIV,FAC MED,DEPT INTERNAL MED 1,FUKUOKA 812,JAPAN
[2] KAGOSHIMA UNIV,FAC MED,DEPT VIROL,KAGOSHIMA 890,JAPAN
[3] KAGOSHIMA UNIV,FAC MED,DEPT INTERNAL MED 3,KAGOSHIMA 890,JAPAN
[4] KAGOSHIMA UNIV,FAC MED,CTR CHRON VIRAL DIS,KAGOSHIMA 890,JAPAN
来源
ACTA NEUROLOGICA SCANDINAVICA | 1996年 / 94卷 / 04期
关键词
human T-cell lymphotropic virus type 1 (HTLV-1); HTLV-1 associated myelopathy tropical spastic paraparesis (HAM/TSP); human leukocyte antigens (HLA); intrathecal immune response; B-cell epitopes;
D O I
10.1111/j.1600-0404.1996.tb07067.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction - In HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP), we correlated human leukocyte antigen (HLA) haplotypes to the fine specificities of intrathecally synthesized IgG antibodies against HTLV-1. Patients and methods - HLA haplotypes of HAM/TSP patients were determined by the standard NIH microcytotoxicity test and family HLA studies. IgG antibodies against HTLV-1 synthetic peptides in paired CSF and serum were measured by enzyme immunoassay, and intrathecal synthesis of antibodies was evaluated. Results - HAM/TSP patients with particular HLA haplotypes (A24Cw7B7DR1DQ5, A2Cw7B7DR1DQ5, A24Cw-B52DR15DQ6, A11Cw1B54DR4DQ4, and A24Cw1B54DR4DQ4) showed more frequently intrathecal synthesis of antibodies against HTLV-1 synthetic peptides, especially against HTLV-1 env gp21 synthetic peptides. Conclusion - In HAM/TSP, a retrovirus-induced human chronic inflammatory disease of the CNS, this is the first report to provide evidence that the intrathecal antiviral immune response is influenced by immunogenetic factors of the HLA complex.
引用
收藏
页码:287 / 293
页数:7
相关论文
共 23 条
[1]  
BODMER JG, 1992, HLA 1991, P17
[2]   ANTIBODY REACTIVITY TO DIFFERENT REGIONS OF HUMAN T-CELL LEUKEMIA-VIRUS TYPE-1 GP61 IN INFECTED PEOPLE [J].
CHEN, YMA ;
LEE, TH ;
SAMUEL, KP ;
OKAYAMA, A ;
TACHIBANA, N ;
MIYOSHI, I ;
PAPAS, TS ;
ESSEX, M .
JOURNAL OF VIROLOGY, 1989, 63 (11) :4952-4957
[3]   IDENTIFICATION OF NOVEL NEUTRALIZATION-INDUCING REGIONS OF THE HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-I ENVELOPE GLYCOPROTEINS WITH HUMAN HTLV-I-SEROPOSITIVE SERA [J].
DESGRANGES, C ;
SOUCHE, S ;
VERNANT, JC ;
SMADJA, D ;
VAHLNE, A ;
HORAL, P .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (02) :163-173
[4]  
GESSAIN A, 1985, LANCET, V2, P407
[5]   DIFFERENT B-CELL RESPONSES TO HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-I (HTLV-I) ENVELOPE SYNTHETIC PEPTIDES IN HTLV-I-INFECTED INDIVIDUALS [J].
IDA, H ;
KURATA, A ;
EGUCHI, K ;
KAWAKAMI, A ;
MIGITA, K ;
FUKUDA, T ;
NAKAMURA, T ;
KUSUMOTO, Y ;
BERZOFSKY, JA ;
NAGATAKI, S .
JOURNAL OF CLINICAL IMMUNOLOGY, 1991, 11 (03) :143-151
[6]   NEUTRALIZING ACTIVITY OF HUMAN-ANTIBODIES AGAINST THE STRUCTURAL PROTEIN OF HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-I [J].
INOUE, Y ;
KURODA, N ;
SHIRAKI, H ;
SATO, H ;
MAEDA, Y .
INTERNATIONAL JOURNAL OF CANCER, 1992, 52 (06) :877-880
[7]   PATHOLOGY OF CHRONIC MYELOPATHY ASSOCIATED WITH HTLV-I INFECTION (HAM TSP) [J].
IWASAKI, Y .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1990, 96 (01) :103-123
[8]  
KITZE B, 1995, ACTA NEUROL SCAND, V92, P213
[9]   Diversity of intrathecal antibody synthesis against HTLV-I and its relation to HTLV-I associated myelopathy [J].
Kitze, B ;
Usuku, K ;
Izumo, S ;
Nakamura, M ;
Shiraki, H ;
Ijichi, S ;
Yashiki, S ;
Fujiyoshi, T ;
Sonoda, S ;
Osame, M .
JOURNAL OF NEUROLOGY, 1996, 243 (05) :393-400
[10]   CHRONIC PROGRESSIVE MYELOPATHY ASSOCIATED WITH HTLV-I - OLIGOCLONAL IGG AND ANTI-HTLV-I IGG ANTIBODIES IN CEREBROSPINAL-FLUID AND SERUM [J].
LINK, H ;
CRUZ, M ;
GESSAIN, A ;
GOUT, O ;
DETHE, G ;
KAMHANSEN, S .
NEUROLOGY, 1989, 39 (12) :1566-1572